Impact of Wideband Late Gadolinium Enhancement Cardiac Magnetic Resonance Imaging on Device-Related Artifacts in Different Implantable Cardioverter-Defibrillator Types.

cardiac magnetic resonance heart failure implantable cardioverter-defibrillator ventricular tachycardia

Journal

Journal of magnetic resonance imaging : JMRI
ISSN: 1522-2586
Titre abrégé: J Magn Reson Imaging
Pays: United States
ID NLM: 9105850

Informations de publication

Date de publication:
10 2021
Historique:
revised: 05 03 2021
received: 03 08 2020
accepted: 10 03 2021
pubmed: 21 3 2021
medline: 30 9 2021
entrez: 20 3 2021
Statut: ppublish

Résumé

Late gadolinium enhancement (LGE) imaging in patients with implantable cardioverter-defibrillators (ICD) is limited by device-related artifacts (DRA). The use of wideband (WB) LGE protocols improves LGE images, but their efficacy with different ICD types is not well known. To assess the effects of WB LGE imaging on DRA in different non-MR conditional ICD subtypes. Retrospective. A total of 113 patients undergoing cardiac magnetic resonance imaging with three ICD subtypes: transvenous (TV-ICD, N = 48), cardiac-resynchronization therapy device (CRT-D, N = 48), and subcutaneous (S-ICD, N = 17). 5 T scanner, standard LGE, and WB LGE imaging with a phase-sensitive inversion recovery segmented gradient echo sequence. DRA burden was defined as the number of artifact-positive short-axis LGE slices as percentage of the total number of short-axis slices covering the left ventricle from based to apex, and was determined for WB and standard LGE studies for each patient. Additionally, artifact area on each slice was quantified. Shapiro-Wilks, Kruskal-Wallis analysis of variance, Dunn tests with Bonferroni correction, and Mann-Whitney U-test. In patients with TV-ICD, DRA burden was significantly reduced and nearly eliminated with WB LGE compared to standard LGE imaging (median [interquartile range]: 0 [0-7]% vs. 18 [0-50]%, P < 0.05), but WB imaging had less of an impact on DRA in the CRT-D (8 [0-23]% vs. 16 [0-45]%, p = 0.12) and S-ICD (60 [15-71]% vs. 67 [50-92]%, P = 0.09) patients. Residual DRA was significantly greater (P < 0.05) for S-ICD compared to other device types with WB LGE imaging, despite the generators of all three ICD types having similar proximity to the heart. The area of S-ICD associated DRA was smaller with WB LGE (P < 0.001) than with standard LGE imaging and the artifacts had different characteristics (dark signal void instead of a bright hyperenhancement artifact). Although WB LGE imaging reduced the burden of DRA caused by S-ICD, the residual artifact was greater than that observed with TV-ICD and CRT-D devices. Further developments are needed to better resolve S-ICD artifacts. 1 TECHNICAL EFFICACY: STAGE: 5.

Sections du résumé

BACKGROUND
Late gadolinium enhancement (LGE) imaging in patients with implantable cardioverter-defibrillators (ICD) is limited by device-related artifacts (DRA). The use of wideband (WB) LGE protocols improves LGE images, but their efficacy with different ICD types is not well known.
PURPOSE
To assess the effects of WB LGE imaging on DRA in different non-MR conditional ICD subtypes.
STUDY TYPE
Retrospective.
POPULATION
A total of 113 patients undergoing cardiac magnetic resonance imaging with three ICD subtypes: transvenous (TV-ICD, N = 48), cardiac-resynchronization therapy device (CRT-D, N = 48), and subcutaneous (S-ICD, N = 17).
FIELD STRENGTH/SEQUENCE
5 T scanner, standard LGE, and WB LGE imaging with a phase-sensitive inversion recovery segmented gradient echo sequence.
ASSESSMENT
DRA burden was defined as the number of artifact-positive short-axis LGE slices as percentage of the total number of short-axis slices covering the left ventricle from based to apex, and was determined for WB and standard LGE studies for each patient. Additionally, artifact area on each slice was quantified.
STATISTICAL TESTS
Shapiro-Wilks, Kruskal-Wallis analysis of variance, Dunn tests with Bonferroni correction, and Mann-Whitney U-test.
RESULTS
In patients with TV-ICD, DRA burden was significantly reduced and nearly eliminated with WB LGE compared to standard LGE imaging (median [interquartile range]: 0 [0-7]% vs. 18 [0-50]%, P < 0.05), but WB imaging had less of an impact on DRA in the CRT-D (8 [0-23]% vs. 16 [0-45]%, p = 0.12) and S-ICD (60 [15-71]% vs. 67 [50-92]%, P = 0.09) patients. Residual DRA was significantly greater (P < 0.05) for S-ICD compared to other device types with WB LGE imaging, despite the generators of all three ICD types having similar proximity to the heart. The area of S-ICD associated DRA was smaller with WB LGE (P < 0.001) than with standard LGE imaging and the artifacts had different characteristics (dark signal void instead of a bright hyperenhancement artifact).
DATA CONCLUSION
Although WB LGE imaging reduced the burden of DRA caused by S-ICD, the residual artifact was greater than that observed with TV-ICD and CRT-D devices. Further developments are needed to better resolve S-ICD artifacts.
LEVEL OF EVIDENCE
1 TECHNICAL EFFICACY: STAGE: 5.

Identifiants

pubmed: 33742522
doi: 10.1002/jmri.27608
pmc: PMC9034356
mid: NIHMS1796357
doi:

Substances chimiques

Contrast Media 0
Gadolinium AU0V1LM3JT

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

1257-1265

Subventions

Organisme : NHLBI NIH HHS
ID : T32 HL007381
Pays : United States

Informations de copyright

© 2021 International Society for Magnetic Resonance in Medicine.

Références

J Cardiovasc Electrophysiol. 2016 Feb;27(2):183-9
pubmed: 26445386
J Cardiovasc Electrophysiol. 2016 May;27(5):571-80
pubmed: 26840595
Am J Cardiol. 2019 Apr 15;123(8):1329-1335
pubmed: 30739658
Europace. 2019 Aug 1;21(8):1220-1228
pubmed: 31131393
Circulation. 2017 Dec 19;136(25):2491-2507
pubmed: 29255125
N Engl J Med. 2017 Feb 23;376(8):755-764
pubmed: 28225684
Heart Rhythm. 2017 Oct;14(10):1487-1493
pubmed: 28603002
Eur Heart J Cardiovasc Imaging. 2018 Sep 1;19(9):1051-1061
pubmed: 29048460
Int J Cardiol. 2019 Mar 15;279:72-78
pubmed: 30642645
Medicine (Baltimore). 2018 Nov;97(46):e12955
pubmed: 30431569
J Cardiovasc Magn Reson. 2019 Aug 15;21(1):50
pubmed: 31412875
Heart Rhythm. 2014 Feb;11(2):289-98
pubmed: 24140812
Heart Rhythm. 2016 Jan;13(1):96-7
pubmed: 26253037
Circ Arrhythm Electrophysiol. 2020 Apr;13(4):e007975
pubmed: 32188287
Europace. 2015 May;17(5):761-6
pubmed: 25687749
Am Heart J. 2020 Mar;221:165-176
pubmed: 31955812
Heart Rhythm. 2018 Feb;15(2):218-225
pubmed: 29017930
Heart Rhythm. 2017 Jul;14(7):e97-e153
pubmed: 28502708
Radiology. 2014 Jan;270(1):269-74
pubmed: 24086074
JACC Clin Electrophysiol. 2017 Sep;3(9):991-1002
pubmed: 29759724
Am Heart J. 2019 Nov;217:131-139
pubmed: 31654943
J Cardiovasc Magn Reson. 2020 May 18;22(1):35
pubmed: 32418537
Clin Imaging. 2018 Jul - Aug;50:294-296
pubmed: 29747127

Auteurs

Amita Singh (A)

Department of Medicine, Section of Cardiology, University of Chicago Medicine, Chicago, Illinois, USA.

Wensu Chen (W)

Department of Medicine, Section of Cardiology, University of Chicago Medicine, Chicago, Illinois, USA.
Cardiology Department, First Affiliated Hospital, Nanjing Medical University, Nanjing, China.

Hena N Patel (HN)

Department of Medicine, Section of Cardiology, University of Chicago Medicine, Chicago, Illinois, USA.

Nazia Alvi (N)

Department of Medicine, Section of Cardiology, University of Chicago Medicine, Chicago, Illinois, USA.

Keigo Kawaji (K)

Department of Medicine, Section of Cardiology, University of Chicago Medicine, Chicago, Illinois, USA.
Department of Biomedical Engineering, Illinois Institute of Technology, Chicago, Illinois, USA.

Stephanie A Besser (SA)

Department of Medicine, Section of Cardiology, University of Chicago Medicine, Chicago, Illinois, USA.

Roderick Tung (R)

Department of Medicine, Section of Cardiology, University of Chicago Medicine, Chicago, Illinois, USA.

Jiangang Zou (J)

Cardiology Department, First Affiliated Hospital, Nanjing Medical University, Nanjing, China.

Roberto M Lang (RM)

Department of Medicine, Section of Cardiology, University of Chicago Medicine, Chicago, Illinois, USA.

Victor Mor-Avi (V)

Department of Medicine, Section of Cardiology, University of Chicago Medicine, Chicago, Illinois, USA.

Amit R Patel (AR)

Department of Medicine, Section of Cardiology, University of Chicago Medicine, Chicago, Illinois, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH